Shanxi Zhendong Pharmaceutical Co.,Ltd (SHE:300158)
China
· Delayed Price · Currency is CNY 5.74
0.00 (0.00%)
Apr 30, 2026, 12:04 PM CST
SHE:300158 Revenue
Shanxi Zhendong Pharmaceutical Co.,Ltd had revenue of 649.13M CNY in the quarter ending March 31, 2026, a decrease of -13.97%. This brings the company's revenue in the last twelve months to 2.68B, down -9.03% year-over-year. In the year 2025, Shanxi Zhendong Pharmaceutical Co.,Ltd had annual revenue of 2.78B, down -6.33%.
Revenue (ttm)
2.68B
Revenue Growth
-9.03%
P/S Ratio
2.05
Revenue / Employee
748.13K
Employees
3,720
Market Cap
5.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.78B | -188.07M | -6.33% |
| Dec 31, 2024 | 2.97B | -654.89M | -18.06% |
| Dec 31, 2023 | 3.63B | -102.54M | -2.75% |
| Jan 1, 2023 | 3.73B | -1.37B | -26.80% |
| Jan 1, 2022 | 5.09B | 245.94M | 5.07% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Luoxin Pharmaceuticals Group Stock | 2.37B |
| Jiangsu Jibeier Pharmaceutical | 964.93M |
| Jiangsu Lianhuan Pharmaceutical | 2.71B |
| Chongqing Pharscin Pharmaceutical | 827.14M |
| HPGC Renmintongtai Pharmaceutical | 10.54B |
| Tianjin Lisheng Pharmaceutical | 1.35B |
| Guizhou Xinbang Pharmaceutical | 5.62B |
| Beijing Science Sun Pharmaceutical | 404.72M |